Skip to site alert.
Skip to content
Join us for the HICCC's 50th Anniversary Symposium on Thursday, September 15.
Our dedicated access representatives can help you make an appointment today.
We work with our communities and patients to remove access barriers to cancer prevention, screening, treatment and survivorship services.
Learn about the research being pursued by members of the Herbert Irving Comprehensive Cancer Center.
We're dedicated to developing the next generation of researchers and physicians through cross-disciplinary training and fellowship programs
Showing 41 - 50 of 240 results.
Timothy Wang, MD, and Kelley Yan, MD, PhD, have each been awarded 2022 Annual Recognition Prizes from the American Gastroenterological Association (AGA).
In a new content series, Notes from the Lab, we spotlight research by the Piero Dalerba lab that aims to predict resistance to immunotherapy in certain colon cancers.
The prestigious Hirschl Trust Research awards enable early-career scientists to conduct high-risk, high-reward studies to improve human health.
Having a rapport with kids is a critical part of the job for Dr. James Church and other Columbia colorectal surgeons who treat people with hereditary colon cancer.
In the early days of Columbia's cancer program, these incredible women physicians and scientists made key discoveries in the field of cancer research and medicine.
As one of the early pioneers of surgical pathology, Dr. Frantz made a series of important cancer discoveries, including key studies of the surgical pathology of insulin-secreting pancreatic tumors.
Dr. Francis Carter Wood's expertise in surgery, pathology, and radiotherapy catapulted him to the forefront as a leading authority on cancer.
Columbia University researchers uncovered a signaling pathway in EGFR-mutant lung cancer responsible for driving recurrence and metastases, spreading to the brain.
A distinguished leader in surgery, medicine, and academia, Dr. Forde applied a strong but gentle approach to enacting change during his longstanding career.
In a new study, researchers demonstrate that applying artificial intelligence to standard-of-care imaging can help predict how well immunotherapy will work for patients with melanoma.